Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
Theaflavin gallate
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
Theaflavin 3,3'-digallate
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
Theaflavin
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020
Thapsigargin
Potential treatment - pre-clinical evidence Natural product Other treatment Feb/03/2021
Thalimonine
Potential treatment - theoretical effect Natural product Antiviral Nov/09/2020
Thalidomide
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/10/2020
Tetrandrine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
Tetracycline
Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/22/2021
Ternatin 4
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Terminalia chebula extract
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Terlipressin
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/07/2020
Terconazole vetranal
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/27/2020
Terbutaline
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/17/2020
Tenofovir
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Teniposide
Potential treatment - theoretical effect Experimental Antiviral Apr/12/2021
Temsirolimus
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021
Temozolomide
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/05/2021
Telaprevir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021
Teicoplanin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021
Tegobuvir
Potential treatment - theoretical effect Experimental Antiviral Aug/24/2020